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study question: What is the intracellular concentration of cryoprotectant (ICCP) in mouse zygotes during vitriﬁcation (VIT) and
slow-freezing (SLF) cryopreservation procedures?
summary answer: Contrary to common beliefs, it was observed that the ICCP in vitriﬁed zygotes is lower than after SLF, although
the solutions used in VIT contain higher concentrations of cryoprotectants (CPs).
what is known already: To reduce the likelihood of intracellular ice crystal formation, which has detrimental effects on cell
organelles and membranes, VIT was introduced as an alternative to SLF to cryopreserve embryos and gametes. Combined with high
cooling and warming rates, the use of high concentrations of CPs favours an intracellular environment that supports and maintains the tran-
sition from a liquid to a solid glass-like state devoid of crystals. Although the up-to-date publications are reassuring in terms of obstetric and
perinatal outcomes after VIT, a fear about exposing gametes and embryos to high amounts of CPs that exceed 3–4-fold those found in SLF
was central to a debate initiated by advocates of SLF procedures.
study design, size, duration: Two experimental set-ups were applied. The objective of a ﬁrst study was to determine the
ICCP at the end of the exposure steps to the CP solutions with our VIT protocol (n ¼ 31). The goal of the second investigation was to
compare the ICCP between VIT (n ¼ 30) and SLF (n ¼ 30). All experiments were performed in triplicates using mouse zygotes. The
study took place at the GIGA-Research Institute of the University of Lie`ge.
participants/materials, setting, methods: Cell volume is modiﬁed by changes in extracellular osmolarity. Hence, we
estimated the ﬁnal ICCP after the incubation steps in the VIT solutions by exposing the cells to sucrose (SUC) solutions with deﬁned mola-
rities. The ICCP was calculated from the SUC concentration that produced no change in cell volume, i.e. when intra- and extracellular osmo-
larities were equivalent. Cell volume was monitored by microscopic cinematography. ICCP was compared between SLF and VIT based on
the principle that a high ICCP lowers the probability of (re)crystallization during warming but increases the probability of over-swelling of the
cell due to fast inﬂow of water. The survival rates of mouse zygotes after SLF or VIT were compared using either (i) various warming rates or
(ii) various concentrations of SUC in the warming dilution medium.
main results and the role of chance: The ICCP in mouse zygotes during the VIT procedure prior to plunging them in
liquid nitrogen was 2.14 M, i.e. one-third of the concentration in the VIT solution. After SLF, the warming rate did not affect the zygote
survival rate. In contrast, only 3/30 vitriﬁed zygotes survived when warmed slowly but as many as 30/30 zygotes survived when warming was
fast (.20 0008C/min). Vitriﬁed zygotes showed signiﬁcantly higher survival rates than slow-frozen zygotes when they were placed directly in
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the culture medium or in solutions containing low concentrations of SUC (P, 0.01). These two experiments demonstrate a lower ICCP
after VIT than after SLF.
limitations, reasons for caution: The results should not be directly extrapolated to other stages of development or to
other species due to possible differences in membrane permeability to water and CPs.
wider implications of the findings: The low ICCP we observed after VIT removes the concern about high ICCP after VIT,
at least in murine zygotes and helps to explain the observed efﬁciency and lack of toxicity of VIT.
study funding / competing interest(s): The study was funded by the FNRS (National Funds for Scientiﬁc Research). The
authors declare that they have no competing interests.
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Introduction
Water is the major component of the cell and its solidiﬁcation is the
main factor that has to be controlled during the process of cryopreser-
vation. Intracellular formation of ice crystals must be avoided during
both cooling and warming phases, in order to avoid its detrimental
effect on cellular organelles and membranes (Luyet, 1937; Leibo
et al., 1978; Mazur et al., 2005).
In order to reduce the likelihood of intracellular ice crystal forma-
tion, vitriﬁcation (VIT) was introduced as an alternative to the slow
freezing (SLF) cryopreservation procedure (Rall and Fahy, 1985;
Massip et al., 1986). VIT abolishes the intracellular ice crystal forma-
tion found during SLF (Quinn, 2010). VIT is the conversion of a super-
viscous, supercooled liquid into a glassy state when it is cooled below
its glass transition temperature (Tg; Fahy et al., 1987).
In the assisted reproduction technology (ART) ﬁeld, it is now recog-
nized that VIT is a very effective way to cryopreserve MII oocytes
(Kuwayama et al., 2005; Cobo et al., 2010, 2012a; Rienzi et al.,
2012), zygotes (Al-Hasani et al., 2007; Vanderzwalmen et al., 2012)
and embryos at different stages of development (Isachenko et al.,
2007; Balaban et al., 2008; Vanderzwalmen et al., 2009; Van Landuyt
et al., 2011; Cobo et al., 2012b). However, since the ﬁrst announce-
ment of successful VIT in a mammalian model in 1985 (Rall and Fahy,
1985) and in human embryos in 1997 (Vanderzwalmen et al., 1997),
more than 10 years elapsed before the emergence of raising interest
and implementation of this technique in the ART disciplines. Although,
reliable and promising results with blastocysts have been published, the
VIT technique gained interest only when it was shown that it was con-
siderably superior to SLF for the cryopreservation of unfertilized human
oocytes (Smith et al., 2010; Martı´nez-Burgos et al., 2011).
How can this reluctance to move to VIT be explained? One part of
the answer concerns the nature of the cryoprotectant solution (CPsol)
used in this technique. By comparison to SLF, higher concentrations
and different types of CPs are used. Exposure of the biological material
to high concentrations of CPsol is one of the conditions that support
the emergence of a glassy state. Usually, oocytes or embryos are ﬁrst
exposed to two non-vitrifying solutions (nVS1 and nVS2) containing
cell-penetrating CPs (2.3–3.2 M; Kuwayama et al., 2005; Vanderzwal-
men et al., 2009). Next, they are exposed for a short time (45–60 s)
to a vitrifying solution (VS) containing high concentrations of penetrat-
ing (4.8–6.4 M; Kuwayama et al., 2005; Vanderzwalmen et al., 2009)
and non-penetrating (0.5–0.75 M) CPs before being plunged into
liquid nitrogen (LN2).
Our protocol (Vanderzwalmen et al., 2009, 2012) allows the CPs to
penetrate the zygote during their exposure to nVS1 and nVS2. The ex-
posure is short and the initial volume of the zygote is not recovered
during this process since there is insufﬁcient time for intra- and extra-
cellular CP concentrations to equilibrate. In the last step, embryos are
exposed to the VS (6.4 M) where sucrose (SUC) and Ficoll, as non-
penetrating CPs, induce dehydration. Thereby various intrinsic
macromolecules like (glyco)proteins, salts and also penetrating CPs
are concentrated, generating an intracellular environment that
enables a vitreous state to be reached and maintained during the
cooling and warming processes.
An extracellular vitriﬁed state is allowed by the high concentrations
of CPs in the VS that encapsulates the embryo in a vitrifying sheath.
Exposure to these high concentrations of CPs rises concerns that
high intracellular concentrations of CPs (ICCPs) might reached
during VIT and be harmful or even toxic for the cell. For a long
time this concern was sufﬁcient to make many practitioners favour
SLF because it uses lower concentrations of penetrating CPsol
(1.5 M) even though very good survival and implantation rates had
been reported with VIT. A serious debate on the safety of exposure
of oocytes or embryos to CP concentrations that exceed 3–4-fold
those found in SLF posed questions about their potential cytotoxicity.
In that context, the aim of this research is to discover how high the
ICCP is when VIT and SLF cryopreservation procedures are
performed.
Two investigations were undertaken with mouse zygotes as models.
The objective of the ﬁrst study was to determine the ICCP at the end
of the exposure steps to the CPsol used in our VIT protocol. The CP
molarity observed inside the cells was then compared with the one in
the VS. The ICCP was estimated using cell volume measurements. For
that purpose, mouse zygotes were exposed to nVS1, nVS2 and VS
before immersing them in SUC solutions with various molarities. No
variation in the cell volume indicated equivalent osmotic pressures
on both sides of the membrane. Using a cinematographic recording
system, we have determined the SUC concentration with which no
modiﬁcation of the cell volume was observed, allowing inference of
the ICCP. We compared it to VS.
The goal of the second study was to evaluate which of the cryo-
preservation techniques (VIT versus SLF) produced the higher ﬁnal
ICCP. A high ICCP decreases the probability of (re)crystallization
during the warming step but increases the probability of over-swelling
of the cell due to fast inﬂow of water. Based on this assumption, two
protocols were designed allowing comparison of the survival rates of
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mouse zygotes after SLF and VIT with (i) various warming rates and (ii)
various concentrations of SUC in the warming dilution medium.
Materials and Methods
Stimulation, retrieval and culture of mouse
zygotes
Only FVB/N inbred mice (Janvier, France) were used in this study. Five to
7-week-old FVB/N females were stimulated with 3.5 IU of pregnant mare
serum gonadotrophin (PMSG; Folligon, Intervet, The Netherlands)
injected i.p. followed by an i.p. injection of 5 IU of human chorionic go-
nadotrophin (hCG; Chorulon, Intervet) 46 h later. Soon after, each
female was mated with a male of the same strain. The mice with a
vaginal plug were sacriﬁced by cervical dislocation 12 h post-coitum; the
ampulla was opened and zygotes were collected and placed in culture in
M16 medium at 378C under 5% CO2.
Cryopreservation protocols
VIT protocol
Exposure steps to the CPsol. All steps were performed at room tempera-
ture (RT 258C). CPsol were prepared in home-made M2 medium
(Quinn et al., 1982). The zygotes were ﬁrst exposed to nVS1: 5% v/v di-
methyl sulfoxide (DMSO, Sigma, Germany)—5% v/v ethylene glycol (EG,
Sigma) (nVS1 ¼ 1.6 M) for 3 min and then to nVS2: 10% v/v DMSO—
10% v/v EG (nVS2 ¼ 3.2 M) for 3 min. Afterwards they were transferred
to VS containing 20% v/v EG—20% v/v DMSO, 25 mM (10 mg/ml) Ficoll
(70 000 MW, Sigma) and 0.5 M SUC (Sigma) (VS ¼ 6.4 M for the pene-
trating CPs) for 45–60 s. As additional control, two alternative solutions
of our VS were used: solution 10/10 (sol 10/10) containing 10% v/v
EG—10% v/v DMSO, 25 mM Ficoll and 0.5 M SUC and solution 25/25
(sol 25/25) containing 25% v/v EG—25% v/v DMSO, 25 mM Ficoll and
0.5 M SUC.
Loading on the carrier and cooling step. Zygotes were placed onto the
Vitrisafe gutter (VitriMed, Austria) in a small quantity of VIT solution
(,1 ml). The gutter was inserted in a 0.3 ml CBS straw (CryoBioSystem,
France) and this latter was immediately sealed at both ends with a thermo-
sealer (SYMS2, CryoBioSystem) before being plunged into LN2. These
processes took no more than 60 s.
The Vitrisafe plug, designed for aseptic VIT ensures the hermetic isola-
tion of the zygotes from the LN2 and thereby recapitulates the aseptic
storage of cells cryopreserved in closed SF devices (Vanderzwalmen
et al., 2009).
SLF procedures
Exposure to the CPsol and freezing. The SLF protocol described by Renard
and Babinet (1984) was used here with minor modiﬁcations. Zygotes were
exposed for 25 min at RT to a 1.5 M solution of 1–2 propanediol (PROH,
Sigma) diluted in M2 medium, before they were loaded in a straw (0.25 ml
French straw, CryoBioSystem). Fifteen zygotes were loaded in each straw.
Straws were then placed in a precooled (08C) freezing machine (Embryo-
Freeze, Biotronics, UK). Temperature was decreased at 28C/min until
278C. Five minutes later, the seeding was performed on one end of
each straw. After 7.5 min, the temperature was decreased at a rate of
0.38C/min until 2358C. At this temperature, the straws were plunged
directly into LN2.
Determination of the ICCP and its
comparison between VIT and SLF
First study
Assessment of the ICCP at the end of the exposure steps to nVS1, nVS2
and VS by cellular volume monitoring. Cells react to changes in extracellular
osmolarity by volume alterations (Fig. 1a). The measure of the osmotic pres-
sure gradient between two solutions separated by a semipermeable mem-
brane is called tonicity. Cells exposed to hypotonic or hypertonic solutions
initially react either by swelling (hypotonic solutions) or by shrinkage (hyper-
tonic solutions) due to ﬂows of water but later recover as permeant solutes
equilibrate across the cell membrane.
We used this mechanism to estimate the ﬁnal ICCP after the exposure
steps to the nVS1, nVS2 and VS, by transferring the zygotes into solutions
containing deﬁned SUC concentrations. We inferred the ICCP from the
molarity of the SUC solution that did not induce any direct change in
the cell volume after exposure, by converting the known osmolarity of
the SUC solution into corresponding molarity.
Assessment of volume variations by microscopic cinematography. Our
method was adapted from the procedure of Paynter et al. (2001). Obser-
vations of the behaviour of mouse zygotes in the various CPsol were per-
formed on the lid of a 10 cm petri dish. Fifty microliters drops of
successive CPsol were aligned one after the other on a horizontal line,
and were covered with mineral oil (Fertipro, Belgium; Fig. 2).
The determination by cell volume variations of ICCP during the various
steps was done on one zygote at a time. To estimate the original volume,
the zygote was ﬁrst kept in M2 culture medium. At the end of the con-
secutive exposures to nVS1 and 2 and VS, the zygote was immersed in
an SUC solution with a deﬁned molarity and the variation of its volume
was recorded. The molarity of the SUC solutions was gradually increased
from 0 to 2.14 M until almost no modiﬁcation of the volume was
observed.
A minimum of three fully interpretable assays was performed for each
SUC concentration. Only zygotes keeping a homogeneous spherical
shape during all the sequential exposure steps were considered for
measurements.
The observations were performed under an inverted microscope (IX51;
Olympus) equipped with a camera (Olympus DP50) and software that
records the pictures (AnalySIS version 3.2; Olympus).
In order to maintain the zygote on the same focal plane during the
transit from one CPsol to the next, a holding pipette ﬁxed on a microma-
nipulator (TransferMan NK2, Eppendorf) was installed. The mineral oil
coverage strongly limited the volume of medium that was transferred
from one droplet to the other, thereby limiting media mixing (Fig. 3B).
The areas of the zygotes were measured manually with the image ana-
lysis software (AnalySIS). The volume of the corresponding zygotes could
then be calculated from their deduced radius. The results were plotted on
a graph representing the volume variations in relation to the exposure time
in the different solutions.
Second study
Comparison of the ICCP after SLF or VIT. The same procedure of volume
follow-up cannot be performed during SLF due to the process itself
(Fig. 1b). After equilibration with 1.5 M PROH, the dehydration of the
cells continues during the slow cooling equilibrium process in reaction
to the extracellular ice crystals formation. During this period the zygote
lies inside a straw ﬁxed in a programmable cooling machine and thereby
is not accessible for any volume variation follow-up. For this reason,
two indirect strategies were adopted to compare the survival rates
between various warming conditions after SLF and VIT procedures, and
therefore, to compare corresponding ICCP levels.
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Strategy number one: comparison of survival rates after VIT or SLF in relation to
the warming rate. Three assays on 10 zygotes each were performed for
both SLF and VIT groups. It is well known that increasing the ICCP
decreases the probability of recrystallization and cell lysis when low
warming rates are applied. According to this assumption, one experiment
was conducted comparing the rates of zygote survival after rapid (378C)
and slow warming (258C) following either SLF or VIT. The warming rate
was estimated for each condition using two digital thermometers (GMH
3230; Greisinger Electronic and 2110T; Research Instruments).
For thawing after SLF, one set of the straws was plunged in a water bath
at 378C until the ice has disappeared (warming rate 22808C/min),
whereas the second set was taken out of the LN2 and kept in the air
until complete melting (warming rate 6808C/min). After thawing, the
straws were emptied in a 30 mm Petri dish containing 3 ml of 1 M SUC
solution. After 5 min, the zygotes were washed twice in M2 medium
before being transferred to 50 ml droplet of M16 medium under oil and
cultured at 388C in an atmosphere containing 5% CO2.
For warming after VIT, the upper end of the protective straw was cut
while still held in LN2, and the Vitrisafe gutter holding the zygotes was
removed. The gutter was then either warmed in the air (warming rate
11408C/min) before being immersed in a 1 M SUC solution, or was dir-
ectly warmed in the 1 M SUC solution (warming rate 21 0008C/min). In
both cases, 0.8 ml of 1 M SUC in a 4-well plate (Nunc, Denmark) at RT
was employed. After 1 min in the 1 M SUC solution, the zygotes were
transferred to 0.75, 0.5, 0.25 and 0.125 M SUC solutions for 1, 1, 2
and 2 min, respectively. Subsequently, the zygotes were directly immersed
in 3 ml of M2 medium for 15 min and rinsed twice before further culture in
Figure 2 Schematic representation of the method used to monitor
the change in volume of zygote during exposure to M2, nVS1, nVS2,
VS and various molarities of SUC. Transfer of one zygote from one
50 ml droplet of CPsol to the other one with the help of a holding
pipette in order to maintain it on the same focal plane. nVS1/2,
non vitrifying solution 1/2; VS, vitrifying solution; SUC, sucrose.
Figure 1 (a) Experimental design for the assessment of the ICCP when VIT cryopreservation procedure was performed. Time point where the
ICCP was evaluated. (b) Experimental design for the comparison of the ICCP between VIT and SLF cryopreservation procedures. Time point
where the ICCPs were compared. nVS1/2, non vitrifying solution 1/2; VS, vitrifying solution; CPsol, cryoprotectant solution.
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50 ml droplet of M16 medium under oil at 388C in an atmosphere contain-
ing 5% CO2.
Strategy number two: comparison of survival rates after VIT or SLF in relation to
dilution in various SUC concentrations. Higher ICCP requires transfer to a
warming medium containing a higher SUC concentration to minimize over-
swelling of the cell due to fast inﬂow of water through the cell membrane.
In this experiment, the percentages of lysed zygotes were evaluated in
SUC-containing warming solutions of increasing concentration, either
after VIT or SLF.
Slow-frozen zygotes were ﬁrst thawed in a 378C water bath and then
transferred to the SUC solution. Vitriﬁed zygotes were directly immersed
in the SUC solution. Various molarities of SUC in M2 medium were used.
The survival rates of the zygotes were determined 3 h after warming.
Statistical analysis
All experiments were repeated at least three times. The results were
pooled. Analyses were performed by Student’s t-test or by x2 test. A
P-value of ,0.05 was considered as statistically signiﬁcant.
Ethical approval
The animal housing and all experimental methods were performed with
the approval of the Animal Ethics Commission of University of Lie`ge,
Belgium (ﬁle nr 297). All procedures were conducted in accordance
with the Federation of European Laboratory Animal Science Associations
guidelines. All the staff working with animals, including researchers fol-
lowed the required legal trainings.
Results
First study: assessment of the ICCP at the
end of the exposure steps to nVS1, nVS2 and
VS by cellular volume monitoring
First, the variations of the cell volume during the exposure steps to the
CPsol: nVS1, nVS2 and VS were determined (Fig. 3). The zygotes (n ¼
31) reacted to exposure to the CPsol by a reduction (shrinkage) fol-
lowed by a partial restoration (swelling) of the initial volume. In the
nVS1, the cell ﬁrst decreased to 58.3+ 5.1% and subsequently recov-
ered to 71.5+3.9% of its initial volume. Hence in nVS2, shrinkage to
59.2+5.0% followed by a swelling to again 71.5+4.8% was
observed. In the VS, only a decrease in cell volume occurred to
ﬁnally reach a mean of 60.5+5.2% of the initial (Fig. 3G).
Shrinkage corresponds to the initial water outﬂow from the zygote
exposed to a hypertonic solution, whereas swelling is due to the subse-
quent inﬂow of penetrating CPs followed by water. The absence of
swelling after cell shrinkage in VS solution is a consequence of the pres-
ence of the non-penetrating CPs SUC and Ficoll in the solution. In nVS1
and nVS2, incomplete equilibration of CPs does not permit to return to
the initial volume (ﬁnal mean volume ¼ 71.5%). Dehydration occurring
immediately after exposure to a more concentrated CPsol increases the
intracellular concentration of previously penetrated CPs.
After the VS step, zygotes were exposed to one of the following
SUC solutions: 0 M (n ¼ 3), 0.30 M (n ¼ 4), 0.45 M (n ¼ 3), 0.82 M
Figure 3 Cinematographic study: evolution of the relative volume of one zygote through the various CPsol. Letters on the graph refer to corre-
sponding pictures. A: t ¼ 0 in M2 medium; B: passage from one drop to another drop through the oil; C: t ¼ 30 s in nVS1; D: t ¼ 180 s: end of the
nVS1 step; E: t ¼ after 30 s in nVS2; F: t ¼ after 180 s in nVS2. G: end of the exposure to VS. V30, volume after 30 s of exposure to a speciﬁc CPsol;
Vend, volume at the end of a period of exposure to a speciﬁc CPsol. nVS1/2, non vitrifying solution 1/2; VS, vitrifying solution.
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(n ¼ 4), 1.40 M (n ¼ 6), 1.82 M (n ¼ 6) and 2.14 M (n ¼ 5) (Fig. 4a).
The cells swelled rapidly when exposed to 0–1.82 M SUC solutions;
the degree of swelling varied from more than doubling of the volume
in 0 M SUC to an increase of 10% in 1.82 M SUC. When incubated
in 2.14 M SUC solution only minimal changes in cell volume occurred.
This reduced volume modiﬁcation indicates that an osmotic
quasi-equilibrium exists between intracellular and extracellular com-
partments. Therefore during VIT, the intracellular osmolarity
approaches 2.14 Osm/L before the zygotes are plunged in LN2.
To conﬁrm that exposing zygotes to nVS1, nVS2 and the routinely
used VS, results in an approximate iso-osmoticity between ICCP and
the 2.14 M SUC solution, we analysed volume variations of mouse
zygotes after exposure to two alternative VS solutions: sol 10/10 or
sol 25/25.
In both supplementary groups, cinematographic analysis was per-
formed on four zygotes per group (n ¼ 9 for sol 10/10; n ¼ 15 for
sol 25/25; Fig. 4b). After 60 s exposure to sol 10/10, we observed
an immediate and dramatic reduction in cell volume upon immersion
in the 2.14 M SUC solution. In contrast, after exposure to sol 25/25,
an increase in volume was observed. We have shown above that after
exposure to VS, only faint variation in the volume was observed,
reﬂecting an iso-osmotic situation. Exposures to the two alternative
solutions reﬂect hypo-osmotic (sol 10/10) or hyper-osmotic (sol
25/25) situations.
Second study: comparison of the ICCP
after SLF or VIT
Figure 5 shows the survival rates after slow or fast warming of 60 vit-
riﬁed and 60 slow-frozen zygotes. After SLF, no signiﬁcant difference in
the survival rates was noticed either if slow warming (80%; 24/30) or
rapid warming (77%; 23/30) was applied. After VIT however, only
10% (3/30) of the zygotes survived when the warming process took
place in air (slow warming). When the tip of the Vitrisafe was directly
plunged in a SUC bath to reach a warming rate of .20 0008C/min,
100% (30/30) of the zygotes survived the warming procedure (rapid
warming). The difference in terms of survival rates was statistically sig-
niﬁcant (P, 0.001).
The survival rates after the transfer of 90 vitriﬁed and 90 slow-
cooled zygotes to various concentrations of SUC solutions after
thawing is presented in Fig. 6. Slow-frozen zygotes that were directly
diluted in the culture medium (0 M SUC) showed a signiﬁcantly
lower (P, 0.001) survival rate (7%; 2/30) than the vitriﬁed zygotes
(37%; 11/30). In the 0.25 M and 0.5 M SUC solutions, survival rates
in the SLF group were 43% (13/30) and 70% (21/30), respectively.
Again, vitriﬁed zygotes showed signiﬁcantly better survival rates with
73% (22/30) in 0.25 M (P, 0.01) and 97% (29/30) in 0.5 M SUC
solutions (P, 0.001).
Discussion
During the VIT process, and before rapidly cooling the biological ma-
terial in LN2, cells are exposed to at least two steps of gradual in-
crease of the concentrations of CPs in the nVS1, nVS2 and VS. The
aim is to create an intracellular environment that supports the transi-
tion from a liquid to a solid glass-like state for deﬁned cooling and
warming rates. This means that before plunging the biological material
in LN2, the intracellular compartment has to be conditioned to allow
the emergence and maintenance of a vitreous state (Fahy et al., 1987).
The fear of exposing gametes and embryos to such high amounts of
CPs was the central part of a debate initiated by advocates of the SLF
procedure, using low concentration of penetrating CP. Indeed, when
compared with SLF where embryos are equilibrated with CPsol of
1.5 M, the ﬁnal concentration of penetrating CPs in the VS is consid-
erably higher, ranging from 4.8 M (Kuwayama et al., 2005) to 6.4 M
(Vanderzwalmen et al., 2009; Quinn, 2010).
To reassure those who are concerned by the high concentration of
CPs in VIT and to provide them with an objective answer, we esti-
mated in this study the ICCP of a vitriﬁed mouse zygote. In a
second approach, we speciﬁed which of both techniques, SLF or
VIT, results in the highest ICCP.
To our knowledge, this is the ﬁrst manuscript reporting an estima-
tion of the true ICCP immediately before plunging the zygote in LN2.
It is well accepted that all CPs are potentially toxic. The impact of the
CPs on the safety of VIT has always been a major scientiﬁc concern. Al-
though the up-to-date publications are reassuring in terms of obstetric
and perinatal outcomes (Chian et al., 2008; Liebermann, 2009; Nagy
et al., 2009; Noyes et al., 2009; Forman et al., 2012; Mukaida et al.,
2012), further studies were necessary to solve the apparent contradic-
tion between the observed efﬁciency/safety of VIT and the anticipated
higher ICCP of vitriﬁed cells. In a recent study, Chatzimeletiou et al.
(2012) analysed blastocysts that were aseptically vitriﬁed. They
concluded that although there was a signiﬁcantly higher incidence of ab-
normal spindles in the vitriﬁed group than in the fresh control, the high
survival rates after thawing and the large proportion of normal spindle/
chromosome conﬁgurations suggested that VIT did not adversely affect
the development of human blastocysts and the ability of spindles to form
and continue normal cell divisions. Additionally, Wirleitner et al. (2012)
showed that the length of the storage period of vitriﬁed blastocysts in
closed devices had no negative impact. Neither survival nor develop-
mental potential were impaired after 6 years in the LN2 tank, nor
was any inﬂuence on the health of born children detected.
If the concentration of CPs had been very high in the cells, would it
have been possible to obtain life birth rates almost comparable with
fresh embryo transfers (Rienzi et al., 2010)? Bearing this in mind, is
it justiﬁed to favour SLF because of concern about the use of high
CPs in VIT?
The reason to use high concentration of CPs in VIT is to embed the
zygote in a vitrifying extracellular sheath to avoid ice crystal formation
that may have detrimental effects. The use of macromolecules such as
Ficoll, that remain outside the cells, increases the medium viscosity
and protects the outer part of the embryo against crystallization. In
general, the VS contains the minimal concentration of CPs that
allows a liquid to reach a vitriﬁed state under deﬁned cooling and
warming conditions.
The cinematographic analysis allowed us also to estimate the degree
of penetration of CPs inside the cells. The concentration of CPs inside
the cell after the two ﬁrst steps of exposure to the ﬁrst two CPsols
(nVS1 and nVS2) was too low to allow a vitriﬁed state to be achieved
and maintained. The zygotes in our VIT protocol did not reach com-
plete equilibration after short periods of exposure to nVS1 and nVS2.
Hence, zygotes were exposed for a brief period to VS containing SUC,
to dehydrate them so that an intracellular vitrifying state could be
established. This increased the intracellular osmolarity following from
6 Vanderzwalmen et al.








Figure 4 (a) Evolution of the relative zygote volume when immersed in solutions with various concentrations of SUC following the exposure steps to
nVS1, nVS2 and VS (Fig. 3). Letters on the graph refer to corresponding pictures. A: end of the exposure to VS (4A is the same time point as Fig. 3G). B–D:
pictures of zygotes when they have reached their maximal volume in SUC solutions of 0, 0.82 and 2.14 M, respectively. (b) Evolution of the relative zygote
volume when immersed in 2.14 M SUC solution following the exposure steps to nVS1, nVS2 and VS or alternative solutions (sol 10/10 or sol 25/25).
nVS1/2, non vitrifying solution 1/2; VS, vitrifying solution; SUC, sucrose.
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increases in the concentrations of the previously entered CPs as well
as intracellular salts and (glyco)proteins. The cytoplasm contains
various intrinsic macromolecules and salts that were concentrated
during the ﬁnal dehydration step favouring the amorphous state.
This in turn generates an intracellular environment that promotes
maintenance of a vitreous state when cells are rapidly plunged into
LN2 or warmed. The CPs are only part of the intracellular solutes
that contribute to the intracellular osmolarity, so the true ICCP is
even lower than 2.14 M. This low ICCP helps to explain why VIT
gives better results than SLF: although high extracellular concentration
of CPs are needed to allow VIT, only a fraction of them enter the cell,
thereby reducing their toxicity.
The next step aimed at comparing the ICCPs after SLF and VIT.
Two experiments have shown that the ICCP was lower in our VIT
protocol than in a conventional SLF protocol.
We observed a signiﬁcantly higher rate of lysed zygotes after SLF
than after VIT whatever the SUC concentration in the medium they
were transferred to after thawing. Immediately after warming, SLF
zygotes presented obvious signs of over-swelling, which ﬁnally
induced the lysis of the zygotes. This can be explained by a rapid
and ﬁnally lethal inﬂow of water into the cells. This is the signature
of a higher intracellular osmolarity in SLF when compared with the
one present in vitriﬁed cells. The higher the ICCP, the higher the
SUC concentration in the warming medium must be to minimize an
over-swelling of the cells.
It has been shown that warming speeds play an even more import-
ant role for cell survival after VIT than the cooling rates (Seki and
Mazur, 2008, 2009). A high warming speed after VIT prevents cell
lysis. This is because in a VIT process, the ICCP is too low to
prevent recrystallization during slow warming when the temperature
exceeds Tg (approximately 21208C). If the warming speed is not
fast enough, the supercooled liquid is rapidly transformed into ice crys-
tals in the interval between Tg and the melting temperature (Tm).
The contrasting observation that survival rates after SLF are poorly
affected by the warming rate, suggests that the ICCP is higher after SLF
and can prevent intracellular crystallization.
As critical warming rates are higher than the critical cooling rates, the
minimal concentration of CPs to prevent re-crystallization during
warming must be higher than during cooling. This means that it might
be easier to maintain a vitriﬁed state during cooling than during the
warming process, given the same concentration of CPs. If the warming
rate is reduced by using devices that insulate the drop containing the
zygotes, thereby increasing thermal inertia, higher ICCPs are needed in
order to reduce the likelihood of re-crystallization. However, these
higher concentrations of CPs might be toxic for the cells.
Out of two studies using mouse zygotes in conjunction with a time
lapse analysis, we can conclude that the ICCP during VIT is a lot lower
than the CP concentrations present in the VS solution. We have
clearly shown that the ICCPs in the vitriﬁed zygotes are, in contrast
to the common beliefs, even lower than the ones observed after a
SLF procedure.
During SLF, when cooling is applied at a rate of 0.38C/min, cells are
equilibrated with a low concentration of a penetrating CP (PROH)
whose concentration increases during all the cooling process as a con-
sequence of the increasing formation of extracellular ice crystals (solu-
tion effect). Knowing that a cell survives a cryopreservation procedure
only if the development of intracellular ice crystals is avoided, survival
after SLF reﬂects the presence of an intracellular vitriﬁed state. SLF has
been the standard cryopreservation method for .25 years without
being aware of the presence of a vitriﬁed intracellular state obtained
with a very high ICCP. So, people anxious of toxic consequences of
high ICCP during cryopreservation should shift from SLF methods to
the VIT protocols achieving consistently lower ICCP. Moreover, this
shift could also be justiﬁed by the much shorter exposure to CPs
during a VIT process than during SLF, and ultimately by the higher ef-
ﬁciency of VIT.
From all these experiments, we can conclude that the ICCP
reached after VIT is not as high as it was previously thought. As a
Figure 6 Percentages of intact zygotes after VIT or SLF in relation
to various SUC concentrations. *P, 0.01, **P, 0.02; 3 replicates of
10 zygotes in each group.Figure 5 Comparison of survival rates after VIT or SLF in relation
to the warming rate. *P, 0.001; 3 replicates of 10 zygotes in each
group.
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consequence, we can demystify the problem of high level of CPs inside
the cell during VIT, thereby solving the apparent contradiction with the
higher VIT efﬁciency. However, this study was performed on mouse
zygotes. A similar experiment should be re-conducted on human
oocytes and embryos to conﬁrm our observations. Nevertheless,
we are quite conﬁdent that our conclusions could be extrapolated
to other species since they reﬂect the efﬁciency and safety of the
VIT procedure reported in the literature.
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